Making A Difference Seven Months Post Infection, SARS-CoV-2 Antibody Immunoglobulin G Either Remains Stable Or Increases: Study BY Outlook Web Desk
Making A Difference Drug Used To Reduce Blood Fat Is Capable Of Cutting Down SARS-CoV-2 Infection By 70 Per Cent: Study BY Outlook Web Desk
Making A Difference Researchers Develop Variants Of More Potent, Stable Nanobodies To Fight SARS-CoV-2 BY Outlook Web Desk
National Phase Three Clinical Trial Concludes 77.8 Per Cent Effectiveness Of Covaxin BY Outlook Web Desk
Making A Difference First Covid-19 Case Could Have Emerged in China in October 2019, Reveals Study BY Outlook Web Bureau
.jpg?auto=format%2Ccompress&fit=max&format=webp&w=300&dpr=1.0)
.jpg?auto=format%2Ccompress&fit=max&format=webp&w=300&dpr=1.0)